Jpmorgan Chase & CO Opko Health, Inc. Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Opko Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 527,411 shares of OPK stock, worth $675,086. This represents 0.0% of its overall portfolio holdings.
Number of Shares
527,411
Previous 527,411
-0.0%
Holding current value
$675,086
Previous $817,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding OPK
# of Institutions
255Shares Held
195MCall Options Held
1.68MPut Options Held
126K-
Rubric Capital Management LP New York, NY47.8MShares$61.2 Million1.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.5MShares$48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY29.2MShares$37.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$14.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9MShares$11.5 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $988M
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...